bf/NYSE:AMRX_icon.png

COM:AMNEAL

Amneal Pharmaceuticals

  • Stock

USD

Last Close

8.32

22/11 21:00

Market Cap

2.19B

Beta: -

Volume Today

749.52K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
1.02B
-
1.03B
1.52%
1.66B
60.88%
1.63B
2.20%
1.99B
22.51%
2.09B
5.08%
2.21B
5.67%
2.39B
8.20%
cost of revenue
420.77M
-
507.48M
20.61%
946.59M
86.53%
1.27B
34.52%
1.36B
7.13%
1.32B
2.89%
1.43B
7.77%
1.57B
10.19%
gross profit
597.46M
-
526.18M
11.93%
716.40M
36.15%
353.00M
50.73%
628.39M
78.02%
768.97M
22.37%
784.71M
2.05%
820.57M
4.57%
selling and marketing expenses
general and administrative expenses
118.76M
-
109.05M
8.18%
230.44M
111.32%
selling general and administrative expenses
118.76M
-
109.05M
8.18%
230.44M
111.32%
289.60M
25.67%
326.73M
12.82%
365.50M
11.87%
399.70M
9.36%
429.68M
7.50%
research and development expenses
204.75M
-
191.94M
6.26%
210.45M
9.65%
202.29M
3.88%
190.59M
5.78%
209.56M
9.96%
200.05M
4.54%
167.78M
16.13%
other expenses
-669K
-
-47K
92.97%
2.85M
6,159.57%
1.47M
48.56%
2.59M
76.79%
15.33M
491.89%
-3.96M
125.83%
5.12M
229.27%
cost and expenses
744.27M
-
808.46M
8.62%
1.39B
71.62%
1.77B
27.23%
1.88B
6.58%
1.90B
0.97%
2.02B
6.51%
2.17B
7.21%
operating expenses
323.50M
-
300.98M
6.96%
440.89M
46.48%
491.88M
11.57%
517.31M
5.17%
575.07M
11.16%
595.79M
3.60%
596.32M
0.09%
interest expense
55.28M
-
71.06M
28.54%
143.57M
102.04%
168.21M
17.16%
146.00M
13.20%
136.32M
6.63%
158.38M
16.18%
210.63M
32.99%
ebitda
306.30M
-
271.08M
11.50%
415.77M
53.37%
69.81M
83.21%
349.06M
400.00%
442.64M
26.81%
446.64M
0.90%
417.96M
6.42%
operating income
284.88M
-
245.10M
13.96%
-19.67M
108.03%
-137.42M
598.54%
91.16M
166.33%
209.24M
129.54%
206.46M
1.32%
204.37M
1.01%
depreciation and amortization
33.02M
-
45.94M
39.13%
137.40M
199.12%
207.24M
50.82%
257.90M
24.45%
233.41M
9.50%
240.18M
2.90%
229.40M
4.49%
total other income expenses net
-3.85M
-
17.19M
546.84%
-334.67M
2,046.88%
-82.82M
75.25%
-126.94M
53.27%
-177.87M
40.13%
-454.59M
155.57%
-13.09M
97.12%
income before tax
214.82M
-
171.32M
20.25%
-202.72M
218.33%
-220.24M
8.64%
-35.78M
83.75%
31.37M
187.66%
-248.13M
891.07%
-40.27M
83.77%
income tax expense
5.39M
-
2.00M
62.97%
-1.42M
171.02%
383.33M
27,114.16%
-104.36M
127.22%
11.20M
110.73%
6.66M
40.50%
8.45M
26.87%
net income
207.38M
-
167.65M
19.16%
-169.73M
201.24%
-603.57M
255.62%
68.58M
111.36%
20.17M
70.59%
-254.79M
1,363.21%
-83.99M
67.03%
weighted average shs out
114.86M
-
114.86M
0%
127.25M
10.79%
132.11M
3.81%
147.44M
11.61%
148.92M
1.00%
150.94M
1.36%
176.14M
16.69%
weighted average shs out dil
114.86M
-
114.86M
0%
127.25M
10.79%
132.11M
3.81%
148.91M
12.72%
151.82M
1.95%
150.94M
0.58%
176.14M
16.69%
eps
1.81
-
1.46
19.34%
-1.33
191.10%
-4.57
243.61%
0.47
110.28%
0.14
70.21%
-1.69
1,307.14%
-0.48
71.60%
epsdiluted
1.81
-
1.46
19.34%
-1.33
191.10%
-4.57
243.61%
0.46
110.07%
0.13
71.74%
-1.69
1,400.00%
-0.48
71.60%

All numbers in USD (except ratios and percentages)